Company overview
Cell Microsystems provides innovative tools and lab services for single cell isolation, 3D cell culture, and analysis, supporting pharma R&D in CRISPR gene editing, stem cell research, organoid development, and cell line engineering. Key products include the CellRaft AIR System for automated monoclonal colony isolation, BioFlux Shear Flow Systems for physiological assays, and IonFlux for automated patch clamp electrophysiology following their acquisition of Fluxion Biosciences. They offer contract research services for custom cell lines and organoids using CellRaft technology, with global distribution.
Structured facts
- Website
- https://cellmicrosystems.com/
- Markets served
- United States & Americas
- Keywords
- single cell isolation, cellraft air, 3d cell culture, organoid development, patch clamp systems
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What are your core products for cell engineering and analysis?
- Core products include CellRaft AIR System for single cell isolation and monoclonal colonies, BioFlux Shear Flow Systems for live cell assays under shear, CERO 3D Cell Culture for organoids, and IonFlux automated patch clamp.
- Do you provide lab services or contract research?
- Yes, expanded in-house lab services include cell line development, custom organoid assays, shear flow analysis, and automated patch clamp using CellRaft technology.
- What geographies do you serve and any regulatory compliance?
- Headquartered in Durham, NC, with multinational operations and distributors like I&L Biosystems in Europe; products support regulated workflows in CRISPR, stem cells, and ion channels for global pharma research.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
